- Home
- JELD vs CVRX Comparison
JELD vs CVRX Comparison
Compare JELD & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JELD | CVRX |
|---|---|---|
| Founded | 1960 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.5M | 139.8M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | JELD | CVRX |
|---|---|---|
| Price | $1.08 | $4.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $3.43 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 1.5M | 279.2K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.02 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,211,181,000.00 | $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | $2.06 | $17.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $0.93 | $4.37 |
| 52 Week High | $6.98 | $11.30 |
Technical Indicators
Market Signals| Indicator | JELD | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 33.02 | 39.68 |
| Support Level | $0.93 | $4.37 |
| Resistance Level | $2.06 | $5.96 |
| Average True Range (ATR) | 0.09 | 0.35 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 6.25 | 5.04 |
Price Performance
Historical ComparisonAbout JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.